335
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor: Replies to Published Manuscripts

De Novo Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview

, MSc, , PharmD, , MD, PhD, , PharmD, PhD, , MD, , MD, PhD, , MD & , MD show all
Pages 1292-1295 | Received 21 Sep 2021, Accepted 23 Nov 2021, Published online: 03 Feb 2022

References

  • Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine. Ocul Immunol Inflamm Publishede September 10, 2021. 1–4. doi:10.1080/09273948.2021.1974492
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.doi:10.1016/S0002-9394(01)00925-4.
  • Lee H, Bae K, Kang SW, et al. Morphologic characteristics of choroid in the major choroidal thickening diseases, studied by optical coherence tomography. Abe T, ed. Plos One. 2016;11(1):e0147139.doi:10.1371/journal.pone.0147139.
  • Papasavvas I, Herbort CP. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthal Inflamm Infect. 2021;11(1):21. doi:10.1186/s12348-021-00251-5.
  • Campos WR, Cenachi SPF, Soares MS, Gonçalves PF, Vasconcelos-Santos DV. Vogt–Koyanagi–Harada -like disease following yellow fever vaccination. Ocul Immunol Inflamm. 2021;29(1):124–127. doi:10.1080/09273948.2019.1661498.
  • Sood AB, O’Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm. 2019;27(4):524–527. doi:10.1080/09273948.2018.1483520.
  • Kim M. Vogt-Koyanagi-Harada Syndrome following influenza vaccination. Indian J Ophthalmol. 2016;64(1):98. doi:10.4103/0301-4738.178141.
  • Cunningham ET, Moorthy RS. Vaccine-associated posterior uveitis. Retina. 2020;40(4):595–598. doi:10.1097/IAE.0000000000002816.
  • Pacheco Y, Acosta-Ampudia Y, Monsalve DM, Chang C, Gershwin ME, Anaya JM. Bystander activation and autoimmunity. J Autoimmun. 2019;103:102301. doi:10.1016/j.jaut.2019.06.012.
  • Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4 + T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci. 2006;47(6):2547.doi:10.1167/iovs.05-1547.
  • Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2–3):87–95. doi:10.1007/s10792-006-9020-y.
  • Beaudoin CA, Jamasb AR, Alsulami AF, et al. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Comput Struct Biotechnol J. 2021;19:3938–3953. doi:10.1016/j.csbj.2021.06.041.
  • Sen S, Kannan NB, Kumar J, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol. Published August 11, 2021. doi:10.1007/s10792-021-01996-7
  • Santamaria A, Chang J, Savarain C. SARS-CoV-2 among the potential viral triggers for Vogt-Konayagi-Harada Disease: first case report and literature review. Ocul Immunol Inflamm Published August 26, 2021. 1–7. doi:10.1080/09273948.2021.1966052
  • Saraceno JJF, Souza GM, Dos Santos Finamor LP, Nascimento HM, Belfort R. Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retin Vitr. 2021;7(1):49. doi:10.1186/s40942-021-00319-3.
  • WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int. Accessed November 5, 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.